Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon terminates development of anecortave acetate in AMD

July 14, 2008

Cerimon commences phase II Simulect study in noninfectious uveitis

July 10, 2008

Recent Allergan patent describes novel agents for glaucoma

July 8, 2008

NanoViricides to initiate animal efficacy studies of EKC-Cide in Japan

July 2, 2008

Three-month safety and efficacy data reported for Medidur FA

July 1, 2008

Lux Biosciences completes enrollment in LUMINATE clinical trial program for Luveniq

June 30, 2008

Merck & Co. initiates phase IIb clinical trial of SurModics' I-vation intravitreal implant

June 30, 2008

FDA approves Sirion's NDA for Durezol in postoperative ocular inflammation and pain

June 27, 2008

Allergan patents novel prostanoid EP2 agonist prodrugs

June 20, 2008

Inotek begins a phase I trial of INO-8875 for the treatment of glaucoma

June 20, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...